aspartic acid has been researched along with Age-Related Osteoporosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Fu, YC; Kang, L; Lee, CY; Lin, CW; Lin, SY; Wang, CK | 1 |
| Chen, Y; Ding, M; Huang, Q; Jin, R; Li, J; Liu, Y; Peng, X; Xie, J; Yu, P; Zhao, C | 1 |
| Cai, K; Dong, Y; Hu, X; Jin, Y; Liu, J; Ma, J; Wu, G; Zhang, H | 1 |
| ISHIGAMI, H | 1 |
| Miyamoto, K; Nishioka, T; Sakura, N; Toshima, K; Yamoto, K; Yokogawa, K | 1 |
| Kang, CM; Kang, HS; Kwak, CS; Lee, MS; Park, SC; Seong, SC; Song, KY | 1 |
| Askew, BC; Brashear, KM; Breslin, MJ; Coleman, PJ; Duggan, ME; Fernandez-Metzler, C; Hartman, GD; Hoffman, WF; Hunt, CA; Hutchinson, JH; Leu, CT; Libby, LA; Lynch, JJ; Lynch, R; Ma, B; McVean, CA; Merkle, KM; Prueksaritanont, T; Rodan, GA; Rodan, SB; Stump, GL; Wallace, AA | 1 |
7 other study(ies) available for aspartic acid and Age-Related Osteoporosis
| Article | Year |
|---|---|
Bone-Targeting Nanoparticles of a Dendritic (Aspartic acid)
Topics: Animals; Aspartic Acid; Biopolymers; Bone and Bones; Gold; Lipids; Minerals; Nanoparticles; Osteoporosis; Polyesters; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Simvastatin | 2022 |
Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis.
Topics: Animals; Aspartic Acid; Bone and Bones; Bone Density Conservation Agents; Calcitonin; Drug Delivery Systems; Durapatite; Female; Femur; Humans; Maleimides; Oligopeptides; Osteoporosis; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2019 |
Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
Topics: Anabolic Agents; Animals; Aspartic Acid; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Drug Delivery Systems; Humans; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis | 2014 |
[EXPERIMENTAL STUDY ON OSTEOPOROSIS USING RI].
Topics: Amino Acids; Aspartic Acid; Calcium Isotopes; Glycine; Metabolism; Mice; Osteoporosis; Proline; Research; Sodium Chloride; Strontium Isotopes; Sulfur | 1964 |
Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol.
Topics: Administration, Intranasal; Animals; Aspartic Acid; beta-Cyclodextrins; Bone and Bones; Dose-Response Relationship, Drug; Drug Carriers; Estradiol; Female; Gas Chromatography-Mass Spectrometry; Mice; Mice, Inbred Strains; Molecular Structure; Osteoporosis; Ovariectomy; Prodrugs; Time Factors; Tissue Distribution | 2006 |
Dehydroepiandrosterone-dependent induction of peroxisomal proliferation can be reduced by aspartyl esterification without attenuation of inhibitory bone loss in ovariectomy animal model.
Topics: Acyl-CoA Dehydrogenase; Adjuvants, Immunologic; Animals; Aspartic Acid; Biomarkers; Calcium; Cholesterol, HDL; Cholesterol, LDL; Dehydroepiandrosterone; Disease Models, Animal; Esterification; Fatty Acid Desaturases; Female; Injections, Intraperitoneal; Liver; Organ Size; Osteoporosis; Ovariectomy; Peroxisomes; Rats; Rats, Sprague-Dawley; Tibia; Triglycerides | 2000 |
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements.
Topics: Amino Acids; Animals; Aspartic Acid; Binding, Competitive; Dogs; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Molecular Mimicry; Oligopeptides; Osteoporosis; Protein Binding; Receptors, Vitronectin; Structure-Activity Relationship | 2002 |